Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The TRIM42 protein is a member of the tripartite motif-containing family, which includes three zinc-binding domains (RING, B-box type 1, and B-box type 2) and a coiled-coil region. It is predicted to enable ubiquitin protein ligase activity and is involved in protein ubiquitination. TRIM42 is associated with diseases such as astigmatism and wrinkly skin syndrome, and it has a paralog in TRIM27. Despite its role in ubiquitination, its specific therapeutic applications or interactions with drugs are not well-documented in the available literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite Motif-Containing Protein 42 (TRIM42).